Pharmatec Engineering ApS: Financial statements 2017
CVR: 37819859
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Pharmatec Engineering ApS (CVR 37819859) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 631,442 and a net result of DKK 19,153 compared with DKK -34,751 the year before. That is a decrease of 10% compared with the year before. Equity in the 2017 report amounted to DKK 636,309. The solvency ratio was 71.9%.
- Gross Profit
- DKK 631,442
- Profit/Loss
- DKK 19,153
- Equity
- DKK 636,309
- Total Assets
- DKK 885,027
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 631 t. | 19 t. | 636 t. | - |
| 2016 | - | 701 t. | -35 t. | 617 t. | - |
Keep an eye on Pharmatec Engineering ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Pharmatec Engineering ApS has published its annual report for 2016. Gross profit came to DKK 701,322, and the net result was DKK -34,751.
About Pharmatec Engineering ApS
Pharmatec Engineering ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kim Fasting. The company is owned by Kim Fasting. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,380,062 and a net result of DKK 2,278,538 compared with DKK 323,508 the year before. Equity in the 2025 report amounted to DKK 4,028,336.